[Chylothorax in a patient with 9-year remission of malignant lymphoma].
We describe a 69-year-old man who developed chylothorax after a 9-year remission of malignant lymphoma. The patient was admitted to our hospital and received exploratory laparotomy for ileus in February 1986. Bulky masses in the posterior mediastinum and the retroperitoneum, and also a jejunal tumor were observed. Fibrosis of the liver was also observed. The jejunal tumor was removed and histological findings revealed diffuse large B-cell malignant lymphoma. He was treated by combination chemotherapy and remission was achieved. He was discharged in June and remained in remission, but was readmitted for right pleural effusion in October 1994. Effusion was chylous and the chylomicron level was estimated to be 181 mg/dl. Liver cirrhosis also developed but there was no chylous ascites. Chylorrhea disappeared after continuous aspiration, but recurred in December. Continuous aspiration was ineffective, therefore 10 KE of OK-432 was administered twice into the pleural cavity, and chylorrhea again disappeared. No findings suggestive of malignant lymphoma were not detected by computerized tomography and gallium scintigram. He was discharged in March 1995 and chylothorax has not recurred since. These findings suggest that the fragility of the thoracic duct which had been infiltrated by malignant lymphoma might increase, resulting in rupture, even if in remission.
Kawachi
Y
Y
Department of Internal Medicine, Takamatsu Red Cross Hospital, Japan.
Watanabe
A
A
Nishihara
T
T
Uchida
T
T
Setsu
K
K
Mori
M
M
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002916:Chylothorax / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000150:complications* / Q000188:drug therapy; D008297:Male; D010844:Picibanil / Q000008:administration & dosage; D012074:Remission Induction; D013997:Time Factors
D000970:Antineoplastic Agents; D010844:Picibanil